Iperionx Ltd. ADR (IPX)
NASDAQ:IPX
Want to see IPX full AI Analyst Report?
Top Page
Iperionx Ltd. ADR
(NASDAQ:IPX)
Select Model
Select Model
Rating:44Neutral
Price Target:
$30.00
▼(-8.76% Downside)
Action:UpgradedDate:04/09/26
The score is held down primarily by weak financial performance (pre-revenue, widening losses, and heavy cash burn implying ongoing funding/dilution risk). Technicals are also bearish with the price well below longer-term moving averages and a negative MACD. Valuation metrics provide limited support because the company is loss-making (negative P/E) and no dividend yield is available.
Positive Factors
Low leverage
A very low debt-to-equity (~0.04) materially reduces near-term refinancing and interest burden risk, giving management flexibility to fund project development via equity or grants. This balance sheet profile supports multi‑quarter R&D and buildout without immediate debt pressure.
Negative Factors
Pre-revenue operations
The company reports zero revenue, so its business model remains unproven at scale. Without commercial sales, forecasting cash conversion or customer traction is speculative, increasing execution risk and lengthening the timeline before self-sustaining operations.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage
A very low debt-to-equity (~0.04) materially reduces near-term refinancing and interest burden risk, giving management flexibility to fund project development via equity or grants. This balance sheet profile supports multi‑quarter R&D and buildout without immediate debt pressure.
Read all positive factors
Iperionx Ltd. ADR (IPX) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.01B
Dividend YieldN/A
Average Volume (3M)163.91K
Price to Earnings (P/E)―
Beta (1Y)1.54
Revenue GrowthN/A
EPS Growth-48.46%
CountryUS
Employees28
SectorBasic Materials
Sector Strength58
IndustryIndustrial Materials
Share Statistics
EPS (TTM)-0.41
Shares Outstanding33,938,408
10 Day Avg. Volume131,948
30 Day Avg. Volume163,910
Financial Highlights & Ratios
PEG Ratio-1.31
Price to Book (P/B)10.04
Price to Sales (P/S)0.00
P/FCF Ratio-23.55
Enterprise Value/Market Cap0.94
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-353.14
Enterprise Value/Ebitda-13.07
Forecast
1Y Price Target
$54.00Price Target Upside64.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-0.96
Revenue Forecast (FY)$5.34M
Iperionx Ltd. ADR Business Overview & Revenue Model
Company Description
IperionX Limited engages in the exploration and development of mineral properties. It explores for epithermal and replacement style precious and base metal mineralization, as well as titanium, rare earth elements, silica sand, and zircon minerals....
How the Company Makes Money
IperionX’s revenue model is tied to commercializing titanium and critical-mineral products and related processing capabilities. In general, the company aims to generate revenue by (1) selling titanium metal products (e.g., titanium powder and/or o...
Iperionx Ltd. ADR Financial Statement Overview
Summary
Income Statement
8
Very Negative
Balance Sheet
56
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -2.68M | -2.27M | -648.22K | -634.11K | -152.90K | -9.38K |
| EBITDA | -72.49M | -37.79M | -22.49M | -16.86M | -21.64M | -8.82M |
| Net Income | -70.16M | -35.35M | -22.23M | -17.44M | -21.52M | -13.28M |
Balance Sheet | ||||||
| Total Assets | 129.16M | 105.03M | 55.44M | 22.80M | 9.91M | 2.79M |
| Cash, Cash Equivalents and Short-Term Investments | 65.83M | 54.81M | 33.16M | 11.94M | 5.67M | 1.70M |
| Total Debt | 4.46M | 3.93M | 1.49M | 975.31K | 543.03K | 475.65K |
| Total Liabilities | 20.95M | 12.59M | 4.10M | 2.24M | 2.49M | 1.03M |
| Stockholders Equity | 108.20M | 92.44M | 51.34M | 20.56M | 7.42M | 1.76M |
Cash Flow | ||||||
| Free Cash Flow | -53.61M | -39.41M | -26.68M | -18.57M | -14.06M | -3.62M |
| Operating Cash Flow | -18.98M | -21.80M | -18.68M | -15.86M | -12.13M | -3.56M |
| Investing Cash Flow | -18.96M | -24.28M | -6.53M | -5.71M | -3.07M | 1.76M |
| Financing Cash Flow | 925.04K | 67.99M | 46.59M | 27.89M | 19.39M | 3.50M |
Iperionx Ltd. ADR Technical Analysis
Negative
32.88
Price Trends
36.68
Negative
38.76
Negative
40.60
Negative
Market Momentum
-0.66
Negative
52.09
Neutral
84.17
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IPX, the sentiment is Negative. The current price of 32.88 is above the 20-day moving average (MA) of 28.05, below the 50-day MA of 36.68, and below the 200-day MA of 40.60, indicating a neutral trend. The MACD of -0.66 indicates Negative momentum. The RSI at 52.09 is Neutral, neither overbought nor oversold. The STOCH value of 84.17 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IPX.
Iperionx Ltd. ADR Risk Analysis
Iperionx Ltd. ADR disclosed 51 risk factors in its most recent earnings report. Iperionx Ltd. ADR reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Iperionx Ltd. ADR Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | $1.43B | -143.02 | -6.14% | ― | 162.80% | -115.63% | |
56 Neutral | $10.89B | -100.09 | -5.04% | ― | 35.12% | -26.93% | |
53 Neutral | $4.80B | -8.77 | -49.89% | ― | ― | -1089.26% | |
50 Neutral | $839.00M | -5.12 | -22.22% | 1.17% | -18.79% | -3530.57% | |
44 Neutral | $1.01B | -0.87 | -35.30% | ― | ― | -48.46% |
* Basic Materials Sector Average
IPX
Iperionx Ltd. ADR
29.05
7.07
32.17%
GSM
Ferroglobe
4.49
1.05
30.49%
UAMY
United States Antimony
9.98
6.77
210.90%
MP
MP Materials
61.30
36.84
150.61%
CRML
Critical Metals Corp
11.38
9.77
606.83%
USAR
USA Rare Earth
22.03
11.52
109.61%
Iperionx Ltd. ADR Corporate Events
IperionX Files December 2025 Half‑Year Results, Revealing Wider Interim Loss
Mar 12, 2026
On March 12, 2026, IperionX Limited filed a Form 6‑K with the U.S. Securities and Exchange Commission, lodging its unaudited condensed consolidated financial statements for the six months ended December 31, 2025, alongside its ASX half‑...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.